Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Multilevel factors shaping blinatumomab delivery across diverse LMICs
Multilevel factors shaping blinatumomab delivery across diverse LMICs

Continuing adjuvant tamoxifen leads to higher quality of life

Dr Shozo Ohsumi - Chief of Breast Oncology, NHO Shikoku Cancer Center, Matsuyama, Japan
Continuing adjuvant tamoxifen leads to higher quality of life ( Dr Shozo Ohsumi - Chief of Breast Oncology, NHO Shikoku Cancer Center, Matsuyama, Japan )
11 Mar 2009

BIG 1-98: Letrozole vs tamoxifen

Dr Alan Coates - School of Public Health, University of Sydney
BIG 1-98: Letrozole vs tamoxifen ( Dr Alan Coates - School of Public Health, University of Sydney )
11 Mar 2009

Poor prognosis on small, HER2 positive tumours

Dr Ana M. Gonzalez-Angula - Department of Breast Medical Oncology, Department of Systems Biology at the University of Texas M.D. Anderson Cancer Center
Poor prognosis on small, HER2 positive tumours ( Dr Ana M. Gonzalez-Angula - Department of Breast Medical Oncology, Department of Systems Biology at the University of Texas M.D. Anderson Cancer Center )
9 Mar 2009

Predictive value of HER2 and topoisomerase II alpha in early breast cancer patients treated with CMF or anthracycline-based adjuvant therapy

Dr Angelo Di Leo - Sandro Pitigliani Medical Oncology Unit, Prato Hospital
Predictive value of HER2 and topoisomerase II alpha in early breast cancer patients treated with CMF or anthracycline-based adjuvant therapy ( Dr Angelo Di Leo - Sandro Pitigliani Medical Oncology Unit, Prato Hospital )
9 Mar 2009

Myelodysplastic Syndromes and Acute Myeloid Leukaemia

Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York
Myelodysplastic Syndromes and Acute Myeloid Leukaemia ( Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York )
19 Feb 2009

How azacitidine works

Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York
How azacitidine works ( Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York )
19 Feb 2009

Effects of Myelodysplastic Syndrome

Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York
Effects of Myelodysplastic Syndrome ( Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York )
19 Feb 2009

Azacitidine for Myelodysplastic Syndrome

Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York
Azacitidine for Myelodysplastic Syndrome ( Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York )
19 Feb 2009

ECCO 15 - ESMO 34 Executive Scientific Programme Committee

ECCO-ESMO Roundtable discussion - Full Version
ECCO 15 - ESMO 34 Executive Scientific Programme Committee ( ECCO-ESMO Roundtable discussion - Full Version )
16 Feb 2009

Winners from the UICC's Cancer Film Festival

Reel Lives: Cancer Chronicles
Winners from the UICC's Cancer Film Festival ( Reel Lives: Cancer Chronicles )
3 Feb 2009

Complex Events and Emergence in Cancer Systems

Dr Sylvia Nagl, University College London
Complex Events and Emergence in Cancer Systems ( Dr Sylvia Nagl, University College London )
28 Jan 2009

Animation of metastasis

Metastasis
Animation of metastasis ( Metastasis )
23 Jan 2009

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation